The mutational constraint spectrum quantified from variation in 141,456 humans
Top Cited Papers
Open Access
- 28 January 2019
- preprint content
- Published by Cold Spring Harbor Laboratory
- p. 531210
- https://doi.org/10.1101/531210
Abstract
Summary: Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes critical for an organism’s function will be depleted for such variants in natural populations, while non-essential genes will tolerate their accumulation. However, predicted loss-of-function (pLoF) variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes1. Here, we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence pLoF variants in this cohort after filtering for sequencing and annotation artifacts. Using an improved human mutation rate model, we classify human protein-coding genes along a spectrum representing tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve gene discovery power for both common and rare diseases.Keywords
This publication has 41 references indexed in Scilit:
- The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and diseaseNucleic Acids Research, 2014
- A framework for the interpretation of de novo mutation in human diseaseNature Genetics, 2014
- Using next-generation sequencing to isolate mutant genes from forward genetic screensNature Reviews Genetics, 2014
- Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype callsNature Biotechnology, 2014
- De novo mutations in schizophrenia implicate synaptic networksNature, 2014
- Genic Intolerance to Functional Variation and the Interpretation of Personal GenomesPLoS Genetics, 2013
- Patterns and rates of exonic de novo mutations in autism spectrum disordersNature, 2012
- A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding GenesScience, 2012
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseThe New England Journal of Medicine, 2006
- Knockouts model the 100 best-selling drugs—will they model the next 100?Nature Reviews Drug Discovery, 2003